BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jain P, Kathuria H, Momin M. Clinical therapies and nano drug delivery systems for urinary bladder cancer. Pharmacol Ther 2021;226:107871. [PMID: 33915179 DOI: 10.1016/j.pharmthera.2021.107871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 de Lima CSA, Varca JPRO, Alves VM, Nogueira KM, Cruz CPC, Rial-hermida MI, Kadłubowski SS, Varca GHC, Lugão AB. Mucoadhesive Polymers and Their Applications in Drug Delivery Systems for the Treatment of Bladder Cancer. Gels 2022;8:587. [DOI: 10.3390/gels8090587] [Reference Citation Analysis]
2 Li X, Chen W, Li R, Chen X, Huang G, Lu C, Wen Z, Peng X, Liu K, Zhang C, Li H, Hu Y, Zhao Z, Tao L, Lai Y. Bladder cancer diagnosis with a four-miRNA panel in serum. Future Oncol 2022. [PMID: 36047424 DOI: 10.2217/fon-2022-0448] [Reference Citation Analysis]
3 Zhao L, Gu X, Jiang F, Li B, Lu S, Wang F, Sun Y, Liu K, Li J. Long-Lasting Proteinaceous Nanoformulation for Tumor Imaging and Therapy. ACS Omega. [DOI: 10.1021/acsomega.2c03561] [Reference Citation Analysis]
4 Shang X, Na X, Wang L, Yang Z, Ren P. Evaluation of a Dual PI3K/mTOR Inhibitor PF-04691502 against Bladder Cancer Cells. Evid Based Complement Alternat Med 2022;2022:8110796. [PMID: 35783514 DOI: 10.1155/2022/8110796] [Reference Citation Analysis]
5 Robeldo T, Ribeiro LS, Manrique L, Kubo AM, Longo E, Camargo ER, Borra RC. Modified Titanium Dioxide as a Potential Visible-Light-Activated Photosensitizer for Bladder Cancer Treatment. ACS Omega 2022;7:17563-74. [PMID: 35664588 DOI: 10.1021/acsomega.1c07046] [Reference Citation Analysis]
6 Cheng L, Yang F, Tang L, Qian L, Chen X, Guan F, Zhang J, Li G. Electrochemical Evaluation of Tumor Development via Cellular Interface Supported CRISPR/Cas Trans-Cleavage. Research 2022;2022:1-12. [DOI: 10.34133/2022/9826484] [Reference Citation Analysis]
7 Xu C, Pei D, Liu Y, Yu Y, Guo J, Liu N, Kang Z. Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma. Front Oncol 2022;12:818860. [PMID: 35299749 DOI: 10.3389/fonc.2022.818860] [Reference Citation Analysis]
8 Zoqlam R, Lazauskaite S, Glickman S, Zaitseva L, Ilie PC, Qi S. Emerging molecular mechanisms and genetic targets for developing novel therapeutic strategies for treating bladder diseases. Eur J Pharm Sci 2022;:106167. [PMID: 35304859 DOI: 10.1016/j.ejps.2022.106167] [Reference Citation Analysis]
9 Liu Q. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer. Front Genet 2021;12:825109. [PMID: 35087575 DOI: 10.3389/fgene.2021.825109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Liu Q. The emerging roles of exosomal long non-coding RNAs in bladder cancer. J Cell Mol Med 2022. [PMID: 34981655 DOI: 10.1111/jcmm.17152] [Reference Citation Analysis]
11 Xu Y, Luo C, Wang J, Chen L, Chen J, Chen T, Zeng Q. Application of nanotechnology in the diagnosis and treatment of bladder cancer. J Nanobiotechnology 2021;19:393. [PMID: 34838048 DOI: 10.1186/s12951-021-01104-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Kathuria H, Handral HK, Cha S, Nguyen DTP, Cai J, Cao T, Wu C, Kang L. Enhancement of Skin Delivery of Drugs Using Proposome Depends on Drug Lipophilicity. Pharmaceutics 2021;13:1457. [PMID: 34575533 DOI: 10.3390/pharmaceutics13091457] [Reference Citation Analysis]
13 Chen S, Deng C, Zheng W, Li S, Liu Y, Zhang T, Zhang C, Fu Y, Miao H, Ren F, Ma X. Cannabidiol Effectively Promoted Cell Death in Bladder Cancer and the Improved Intravesical Adhesion Drugs Delivery Strategy Could Be Better Used for Treatment. Pharmaceutics 2021;13:1415. [PMID: 34575494 DOI: 10.3390/pharmaceutics13091415] [Reference Citation Analysis]
14 Xia W, Tao Z, Zhu B, Zhang W, Liu C, Chen S, Song M. Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy. Int J Mol Sci 2021;22:9118. [PMID: 34502028 DOI: 10.3390/ijms22179118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]